Ascendis Pharma
ASND
#1252
Rank
C$25.78 B
Marketcap
C$393.15
Share price
3.12%
Change (1 day)
29.45%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): C$19.11

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is C$19.50. In 2025 the company made an earnings per share (EPS) of C-$6.12 an increase over its 2024 EPS that were of C-$10.16.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$19.11-412.58%
2025C-$6.12-39.79%
2024C-$10.16-23.17%
2023C-$13.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
C-$0.23-101.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
C-$7.46-138.26%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
C-$13.83-170.93%๐Ÿ‡บ๐Ÿ‡ธ USA